Business Description
60 Degrees Pharmaceuticals is a Washington, D.C.-based company focused on developing and selling treatments for infectious diseases. Its main product, Arakoda, is an approved therapy for malaria prevention, while its pipeline includes tafenoquine, which is being studied for conditions such as COVID-19, babesiosis, and fungal infections, as well as celgosivir for dengue and Zika. The company works with Tufts Medical Center under a licensing agreement to advance tafenoquine for babesiosis treatment and prevention.
